REFERENCES
- Davies GL, Balart LA, Schifi ER et al., Hepatitis Interventional Therapy Group. Treatment of hepatitis C with recombinant interferon alpha. A multicenter, randomized, controlled trial, N Engl J Med 321, 1501–1506(1989).
- Ronnblom LE, Aim GV, Oberg KE, Possible induction of systemic lupus erythematosus by interferon a treatment in a patient with a malignant carcinoid tumor, J Intern Med 227, 207–210 (1990).
- Garcia-Porrua C, Gonzalez-Gay MA, Fernandez-Lamelo F et al, Simultaneous development of SLE-like syndrome and autoimmune thyroiditis following a-interferon treatment, Clin Exp Rheumatol 16, 107–108 (1998).
- Iguchi H, Kishi M, Fujioka T et al., Polymyositis after interferon f3 treatment of chronic hepatitis type C, Clin Neurol 36, 22–24 (1996).
- Arai H, Tanaka M, Ohta K et al, Symptomatic myopathy associated with interferon therapy for chronic hepatitis C, Lancet 345, 582 (1995).
- Prior C, Haslam PL, In vivo levels and in vitro production of interferon-gamma in fibrosing interstitial lung disease, Clin Exp Immunol 88, 280–287 (1992).
- Stevens W, Vancheeswaran R, Black CM, Alpha interferon-2a (Roferon-A) in the treatment of diffuse cutaneous systemic sclerosis: a pilot study, Br J Rheumatol 31, 683–689 (1992).
- Hooks JJ, Moutsopoulus HM, Geis SA et ai, Immune interferon in the circulation of patients with autoimmune disease, N Engl J Med 301, 4–8 (1979).
- Nagayama Y, Ohta K, Tsuruta M et ai, Exacerbation of thyroid autoimmunity by interferon a treatment in patients with chronic viral hepatitis: our studies and review of the literature, EndocrJ 41, 565 (1994).
- Pittau E, Bogliolo A, Tinti A et al, Development of arthritis and hypothyroidism during alpha-interferon therapy for chronic hepatitis C, Clin Exp Rheumatol 15, 415–419 (1997).
- Taniguchi O, Miyajima H, Hirano T et al, The Leu-1 B-cell subpopulation in patients with rheumatoid arthritis, J Clin Immunol 1, 441–448 (1987),
- Vallisa D, Cavanna L, Berte R et al, Autoimmune thyroid dysfunction in hematologic malignancies treated with alpha-interferon, Acta Haematol 93, 31–35 (1995).
- Yamada G, Tsuji T, Immunological mechanism of chronic liver injury in viral hepatitis, Intern Med 32, 911–913(1993).
- Mishiro S, Hoshi Y, Takeda K et al, Non-A, non-B hepatitis specific antibodies directed at host-derived epitope: implication for an autoimmune process, Lancet 336, 1400–1403 (1990).